What was the primary focus of the Food and Drug Administration Modernization Act (FDAMA)?

The Food and Drug Administration Modernization Act (FDAMA) primarily focused on updating and streamlining the regulatory framework surrounding the compounding of prescription medications. This act, enacted in 1997, aimed to improve and clarify the regulations related to the compounding process, thus enhancing patient safety and access to compounded medications. It addressed the specific needs of pharmacies that compound medications to meet individual patients' needs, ensuring that they could do so in a manner that complied with modern standards of practice.

While prescription drug pricing, advertising, and pharmacy licensing are significant aspects of the pharmaceutical industry, they are not the central themes of FDAMA. For instance, though FDAMA touches upon certain advertising provisions, its core purpose is more directly tied to the rules and regulations governing how prescriptions can be compounded by pharmacies. This makes the focus on prescription compounding regulations a cornerstone of what FDAMA aims to achieve in the context of pharmacy practice.